Has Brian King, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,965 in general payments to Brian King, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian King, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian King, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian King, MD

MOHS-Micrographic Surgery · Vestavia Hls, ALNPI 1407274756

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $601 and has fallen 65.5% since, to $207 in 2025.

$1,965in general payments, 2019–2025

Across 57 payments — averaging $34.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$425
Organogenesis Inc.$212
Novartis$177
Ortho Dermatologics, A Division Of Bausch Health US, LLC$158
Bioventus LLC$149
Kerecis Limited$148
plus $696 from 15 others

What the payments were for

Food & beverage$1,965100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	10	$425
Organogenesis Inc.	7	$212
Novartis	8	$177
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$158
Bioventus LLC	1	$149
Kerecis Limited	2	$148
Verrica Pharmaceuticals Inc.	2	$140
Sanofi	1	$121
Regeneron Healthcare Solutions, Inc.	6	$101
Sun Pharmaceutical Industries Inc.	2	$45
LEO Pharma Inc.	2	$44
Arcutis Biotherapeutics, Inc.	2	$37
Amgen	2	$35
Pfizer	2	$31
Smith+Nephew	1	$27
Johnson & Johnson	1	$24
Integra Lifesciences Corporation	1	$21
Dermavant Sciences, Inc.	1	$19
Zyla Life Sciences, Inc.	1	$18
Genentech USA, Inc.	1	$18
Galderma Laboratories, L.p.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few mohs-micrographic surgery providers in Alabamato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$1,802,476

Medicare patients

999

Services billed

5,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mupirocin	1,808	$15,028
Doxycycline Hyclate	1,752	$14,010
Clobetasol Propionate	45	$4,240
Ketoconazole	79	$2,297
Metronidazole	12	$815
Fluorouracil	11	$755
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	95	$291
Triamcinolone Acetonide	28	$274
Cephalexin	67	$229
Azithromycin	12	$102
Doxycycline Monohydrate	11	$92
ValacyclovirValacyclovir Hcl	16	$41
Tramadol Hcl	19	$23

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Vestavia Hls

Christopher HarmonVestavia Hls$748
Gary MonheitBirmingham$37K
Jeffrey StrickerDothan$10K
Adam RichardsonNorthport$8K
Albert RiveraMadison$6K
Vernon ForresterMadison$4K
Michael HadleyBirmingham$3K
Scott FreemanMobile$3K
Bailey TayebiBirmingham$3K
Conway HuangBirmingham$3K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →